Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ABBV-637 |
Trade Name | |
Synonyms | ABBV637|ABBV 637 |
Drug Descriptions |
ABBV-637 is a biological agent targeting EGFR, and potentially results in cell killing of EGFR expressing tumor via an undisclosed mechanism (NCI Drug Dictionary). |
DrugClasses | EGFR Inhibitor (Pan) 62 |
CAS Registry Number | NA |
NCIT ID | C180902 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ABBV-637 | ABBV-637 | 0 | 1 |
ABBV-637 + Docetaxel | ABBV-637 Docetaxel | 0 | 1 |
ABBV-637 + Osimertinib | ABBV-637 Osimertinib | 0 | 1 |